BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31163475)

  • 1. [Cancer Surveillance in Inflammatory Bowel Diseases].
    Lissner D; Siegmund B
    Dtsch Med Wochenschr; 2019 Jun; 144(11):753-756. PubMed ID: 31163475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
    Chaparro M; Trapero-Marugán M; Guijarro M; López C; Moreno-Otero R; Gisbert JP
    J Crohns Colitis; 2013 Mar; 7(2):e61-5. PubMed ID: 22552273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU; Broomé U; Persson B
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children.
    Lee WS; Karthik SV; Ng RT; Ong SY; Ong C; Chiou FK; Wong SY; Quak SH; Aw MM
    Pediatr Neonatol; 2019 Aug; 60(4):396-404. PubMed ID: 31409456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary sclerosing cholangitis and inflammatory bowel disease].
    Schrumpf E; Fausa O; Aadland E; Elgjo K; Kolmannskog F
    Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1212-6. PubMed ID: 1970674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
    Vetter C
    MMW Fortschr Med; 2005 Mar; 147(13):10. PubMed ID: 15832752
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L; Lapidus A; Ost A; Bergquist A
    Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestyramine treats primary sclerosing cholangitis-associated inflammatory bowel disease.
    Pavlidis P; Heneghan M; Hayee B
    J Crohns Colitis; 2015 Feb; 9(2):210. PubMed ID: 25518061
    [No Abstract]   [Full Text] [Related]  

  • 12. Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
    Stokkeland K; Höijer J; Bottai M; Söderberg-Löfdal K; Bergquist A
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1860-1866.e1. PubMed ID: 30448601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease.
    Cox KL; Cox KM
    J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):580-3. PubMed ID: 9822326
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymyositis, alopecia universalis, and primary sclerosing cholangitis in a patient with Crohn's disease.
    Seibold F; Klein R; Jakob F
    J Clin Gastroenterol; 1996 Sep; 23(2):121-4. PubMed ID: 8877639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colitis cancer--myth or reality?].
    Hertervig E; Befrits R; Ekbom A; Karlén P; Lindberg J; Löfberg R; Rutegård J; Sjöqvist U; Ost A
    Lakartidningen; 2009 Nov 4-12; 106(45):3000-2. PubMed ID: 19998826
    [No Abstract]   [Full Text] [Related]  

  • 17. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Gurbuz AK; Giardiello FM; Bayless TM
    Dis Colon Rectum; 1995 Jan; 38(1):37-41. PubMed ID: 7813342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects.
    Rabinovitz M; Gavaler JS; Schade RR; Dindzans VJ; Chien MC; Van Thiel DH
    Hepatology; 1990 Jan; 11(1):7-11. PubMed ID: 2295474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Colon Cancer and Recommended Surveillance Strategies in Patients with Ulcerative Colitis.
    Rabbenou W; Ullman TA
    Gastroenterol Clin North Am; 2020 Dec; 49(4):791-807. PubMed ID: 33121696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal inflammation and cancer.
    Ullman TA; Itzkowitz SH
    Gastroenterology; 2011 May; 140(6):1807-16. PubMed ID: 21530747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.